How long does it take for GLP-1 medication to work?

If you've just started, or are about to start, a GLP-1 medication for weight loss, it's normal to want to know when you'll actually feel or see something change. The honest answer is that it happens in stages, not all at once. Some effects start within days. Others take months to build up, mainly because your dose is increased gradually rather than starting at full strength.

This guide walks through that timeline across the main weight-loss GLP-1 medications available in the UK: semaglutide (Wegovy, as both a weekly injection and a daily tablet), tirzepatide (Mounjaro), liraglutide (Saxenda, and its generic versions), and orforglipron (Foundayo, daily tablet). It covers what's driving the pace for each, and what can make it faster or slower for you.

Most people notice reduced appetite within the first one to two weeks. Measurable weight loss on the scale usually follows from around week four to eight. But the medications are designed to be started on a low dose and increased slowly over several months, so their full effect typically isn't reached until you're on your maintenance dose, usually somewhere between three and five months in.

GLP-1 medications aren't started at the dose that produces the greatest results. They're started low and increased in steps, usually every four weeks, because raising the dose too quickly makes nausea and other digestive side effects far more likely. This "start low, go slow" approach is built into the prescribing information for all of these medications, though exactly how long the steps take varies by product.

For semaglutide injections (Wegovy), the licensed dosing schedule takes 16 weeks to reach the standard maintenance dose, moving through several smaller doses along the way. For tirzepatide (Mounjaro), the dose is also increased in steps, with a minimum of four weeks between each increase, until you and your prescriber settle on the dose that works for you. Saxenda (liraglutide) is increased weekly rather than monthly, so it reaches its full dose fastest, in around four weeks. The newer daily tablets, Wegovy's oral tablet and Foundayo (orforglipron), are titrated more slowly still, and can take three to five months or more to reach their highest routine dose.

That means the first few months of treatment are as much about your body adjusting to the medication as they are about weight loss itself. It's a deliberate trade-off: a slower start in exchange for fewer side effects along the way.

The pattern below is typical for the weekly injections, Wegovy and Mounjaro. If you're on Saxenda or one of the newer daily tablets, see the medication-by-medication breakdown further down, since their timelines look quite different.

Many people notice their appetite changing within the first one to two weeks, even on the lowest starting dose. This can show up as feeling full sooner, less interest in snacking, or fewer food cravings. The scale may not have moved much yet, and that's expected at this stage.

This is usually when the first dose increase happens, and when many people start to see measurable weight loss. Appetite reduction tends to become more noticeable as the dose goes up.

Most people reach their maintenance dose somewhere in this window, depending on how their titration schedule and any side effects have gone. This is generally where the medication's fuller effects on appetite and weight become apparent.

The pace above is typical for the weekly injections. Here's roughly how long each medication takes to reach its highest routine dose:

Saxenda and generic liraglutide, sold under names including Nevolat and Biolide, are the same medication, so the timeline is identical. Foundayo and the Wegovy tablet are newer options that became available in the UK during 2026, and for now are only accessible on private prescription.

Most of these medications have a formal review point built into their licensing, but it isn't measured the same way for each, and it isn't six months for all of them:

Your prescriber will let you know when your specific review is due.

Clinical trial averages describe what happened across large groups of people, not what will happen to you specifically. Individual response varies quite a bit, and several things can influence your own timeline:

It's worth checking in with your GP, pharmacist, or prescriber if:

Your prescriber can look at your specific dose, history, and progress in a way general guidance can't.